MEI Pharma, Inc. (MEIP) has 39 open-market insider trades by 20 insiders since 2012. The most active filer is Charles V. Baltic III, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jeani Delagardelle | 10% | — | 2 | $6.2M | 2015-03-24 |
| Vivo Ventures Fund VII, L.P. | 10% | — | 3 | $6.1M | 2013-10-02 |
| Vivo Ventures VII Affiliates Fund, L.P. | 10% | — | 2 | $4.3M | 2013-10-29 |
| James Niedel | 10% | — | 1 | $3.3M | 2013-02-19 |
| Ronald Hunt | 10% | — | 2 | $2.2M | 2014-12-09 |
| New Leaf Ventures II, L.P. | 10% | — | 1 | $2.2M | 2013-04-19 |
| Moez Kassam | 10% Owner | — | 1 | $938K | 2023-10-20 |
| Jacob Ma-Weaver | 10% Owner | — | 2 | $845K | 2023-10-11 |
| VIVO Ventures Vii, LLC via Gaurav Aggarwal | 10% | — | 1 | $720K | 2015-11-09 |
| Vivo Ventures Fund V, L.P. | 10% | — | 1 | $343K | 2013-10-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Bruce Ross Winson | 10% Owner | Buy | $329K | 2023-09-22 |
| Jacob Ma-Weaver | 10% Owner | Buy | $219K | 2023-09-22 |
| Jacob Ma-Weaver | 10% Owner | Buy | $626K | 2023-09-20 |
| Moez Kassam | 10% Owner | Buy | $938K | 2023-09-20 |
| Charles V. Baltic III | Director | Buy | $19K | 2023-02-28 |
| Frederick W. Driscoll | Director | Sell | $101K |
Companies that share insiders with MEIP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-02-23 |
| Daniel P. Gold Ph.D. | CEO | Buy | $30K | 2019-12-19 |
| Thomas C. Reynolds | Director | Buy | $16K | 2019-12-19 |
| Frederick W. Driscoll | Director | Buy | $100K | 2019-12-19 |
| Brian G. Drazba | CFO | Buy | $20K | 2019-12-19 |
| Christine Anna White | Director | Buy | $26K | 2019-09-06 |
| David M. Urso | COO | Sell | $34K | 2018-08-07 |
| Charles V. Baltic III | Director | Buy | $25K | 2017-11-27 |
| Charles V. Baltic III | Director | Sell | $24K | 2017-11-27 |
| Vivo Ventures V, LLC | 10% | Sell | $42K | 2015-11-05 |